HEADER IMMUNE SYSTEM 06-FEB-09 2WAH TITLE CRYSTAL STRUCTURE OF AN IGG1 FC GLYCOFORM (MAN9GLCNAC2) COMPND MOL_ID: 1; COMPND 2 MOLECULE: IG GAMMA-1 CHAIN C REGION; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: IMMUNOGLOBULIN GAMMA, FC, RESIDUES 120-328; COMPND 5 SYNONYM: IGG1 FC; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 OTHER_DETAILS: HOMOGENOUS (MAN)9(NAG)2 GLYCOFORM OF HUMAN IGG1 FC. SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 7 EXPRESSION_SYSTEM_CELL_LINE: HEK293T; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PHLSEC KEYWDS IMMUNOGLOBULIN C REGION, ANTIBODY ENGINEERING, IMMUNOGLOBULIN DOMAIN, KEYWDS 2 SECRETED, ANTIBODY, KIFUNENSINE, GLYCOPROTEIN, OLIGOMANNOSE, IMMUNE KEYWDS 3 SYSTEM, GLYCOSYLATION EXPDTA X-RAY DIFFRACTION AUTHOR M.CRISPIN,T.A.BOWDEN,C.H.COLES,K.HARLOS,A.R.ARICESCU,D.J.HARVEY, AUTHOR 2 D.I.STUART,E.Y.JONES REVDAT 7 13-NOV-24 2WAH 1 REMARK REVDAT 6 13-DEC-23 2WAH 1 HETSYN REVDAT 5 29-JUL-20 2WAH 1 COMPND REMARK HETNAM LINK REVDAT 5 2 1 SITE ATOM REVDAT 4 28-FEB-18 2WAH 1 SOURCE REVDAT 3 13-JUL-11 2WAH 1 VERSN REVDAT 2 14-APR-09 2WAH 1 JRNL REVDAT 1 10-MAR-09 2WAH 0 JRNL AUTH M.CRISPIN,T.A.BOWDEN,C.H.COLES,K.HARLOS,A.R.ARICESCU, JRNL AUTH 2 D.J.HARVEY,D.I.STUART,E.Y.JONES JRNL TITL CARBOHYDRATE AND DOMAIN ARCHITECTURE OF AN IMMATURE ANTIBODY JRNL TITL 2 GLYCOFORM EXHIBITING ENHANCED EFFECTOR FUNCTIONS JRNL REF J.MOL.BIOL. V. 387 1061 2009 JRNL REFN ISSN 0022-2836 JRNL PMID 19236877 JRNL DOI 10.1016/J.JMB.2009.02.033 REMARK 2 REMARK 2 RESOLUTION. 2.51 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0047 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.51 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.87 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.5 REMARK 3 NUMBER OF REFLECTIONS : 18192 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.219 REMARK 3 R VALUE (WORKING SET) : 0.216 REMARK 3 FREE R VALUE : 0.268 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT : 988 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.51 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.57 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1230 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 91.93 REMARK 3 BIN R VALUE (WORKING SET) : 0.2760 REMARK 3 BIN FREE R VALUE SET COUNT : 68 REMARK 3 BIN FREE R VALUE : 0.3670 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3327 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 144 REMARK 3 SOLVENT ATOMS : 94 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.57 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.64000 REMARK 3 B22 (A**2) : 0.04000 REMARK 3 B33 (A**2) : 1.61000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.530 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.306 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.220 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 21.412 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.935 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.895 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3580 ; 0.010 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 2429 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4898 ; 1.321 ; 2.007 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5940 ; 0.822 ; 3.003 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 414 ; 6.426 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 152 ;36.316 ;25.000 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 578 ;16.303 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 12 ;15.995 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 571 ; 0.075 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3840 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 638 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2098 ; 0.407 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 813 ; 0.088 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3447 ; 0.774 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1482 ; 1.344 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1451 ; 2.248 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 236 A 338 REMARK 3 ORIGIN FOR THE GROUP (A): -15.3660 -17.5690 13.6080 REMARK 3 T TENSOR REMARK 3 T11: 0.2122 T22: 0.3742 REMARK 3 T33: 0.0720 T12: -0.0040 REMARK 3 T13: 0.0057 T23: 0.1026 REMARK 3 L TENSOR REMARK 3 L11: 4.1203 L22: 3.6402 REMARK 3 L33: 5.2689 L12: 1.8272 REMARK 3 L13: -1.3282 L23: -0.4233 REMARK 3 S TENSOR REMARK 3 S11: -0.0622 S12: 1.1707 S13: 0.3155 REMARK 3 S21: -0.5709 S22: 0.2729 S23: -0.0659 REMARK 3 S31: -0.4581 S32: -0.1698 S33: -0.2107 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 339 A 444 REMARK 3 ORIGIN FOR THE GROUP (A): -5.3940 -28.5370 42.5740 REMARK 3 T TENSOR REMARK 3 T11: 0.0516 T22: 0.0186 REMARK 3 T33: 0.0094 T12: 0.0134 REMARK 3 T13: -0.0020 T23: -0.0113 REMARK 3 L TENSOR REMARK 3 L11: 5.9155 L22: 2.5906 REMARK 3 L33: 3.2045 L12: -0.4624 REMARK 3 L13: 1.8243 L23: 0.4308 REMARK 3 S TENSOR REMARK 3 S11: -0.1499 S12: -0.2769 S13: 0.2290 REMARK 3 S21: 0.3323 S22: 0.1088 S23: -0.0018 REMARK 3 S31: -0.1120 S32: 0.0166 S33: 0.0411 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 237 B 338 REMARK 3 ORIGIN FOR THE GROUP (A): 16.0370 -49.1410 11.0780 REMARK 3 T TENSOR REMARK 3 T11: 0.2175 T22: 0.7240 REMARK 3 T33: 0.4793 T12: -0.0396 REMARK 3 T13: 0.0165 T23: -0.5635 REMARK 3 L TENSOR REMARK 3 L11: 3.9073 L22: 3.1908 REMARK 3 L33: 7.4650 L12: 0.9378 REMARK 3 L13: 2.8376 L23: 1.8284 REMARK 3 S TENSOR REMARK 3 S11: -0.1820 S12: 1.4217 S13: -0.8940 REMARK 3 S21: -0.5771 S22: -0.2293 S23: 0.4241 REMARK 3 S31: 0.2799 S32: 0.1270 S33: 0.4113 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 339 B 444 REMARK 3 ORIGIN FOR THE GROUP (A): 5.1960 -41.3940 41.6660 REMARK 3 T TENSOR REMARK 3 T11: 0.0173 T22: 0.0562 REMARK 3 T33: 0.0305 T12: -0.0099 REMARK 3 T13: 0.0011 T23: 0.0269 REMARK 3 L TENSOR REMARK 3 L11: 6.3155 L22: 4.2204 REMARK 3 L33: 3.1553 L12: 0.0525 REMARK 3 L13: -1.3686 L23: -1.3573 REMARK 3 S TENSOR REMARK 3 S11: -0.1297 S12: -0.2805 S13: -0.4110 REMARK 3 S21: 0.1525 S22: 0.0975 S23: -0.0730 REMARK 3 S31: 0.1271 S32: -0.2882 S33: 0.0321 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 2WAH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 06-FEB-09. REMARK 100 THE DEPOSITION ID IS D_1290038635. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-OCT-07 REMARK 200 TEMPERATURE (KELVIN) : 77.2 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : BM14 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97626 REMARK 200 MONOCHROMATOR : SINGLE SILICON (111) REMARK 200 MONOCHROMATOR REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19180 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.510 REMARK 200 RESOLUTION RANGE LOW (A) : 29.870 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.5 REMARK 200 DATA REDUNDANCY : 4.900 REMARK 200 R MERGE (I) : 0.10000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 17.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.1 REMARK 200 DATA REDUNDANCY IN SHELL : 4.70 REMARK 200 R MERGE FOR SHELL (I) : 0.84000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2DTQ REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.90 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG 6000, 0.1 M MES PH 6.0 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.69550 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 74.60000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.48850 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 74.60000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.69550 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.48850 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 3360 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 28540 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -9.9 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, THR 276 TO ALA REMARK 400 ENGINEERED RESIDUE IN CHAIN B, THR 276 TO ALA REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 237 REMARK 465 PRO A 445 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O3 MAN C 6 O HOH A 2054 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OD1 ASN A 389 O ASN B 389 3555 2.06 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 327 51.04 -104.26 REMARK 500 PRO B 238 128.08 -37.68 REMARK 500 GLU B 272 116.41 -32.81 REMARK 500 GLN B 295 -149.41 -92.04 REMARK 500 SER B 298 59.71 38.00 REMARK 500 ASN B 434 18.22 56.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ASN B 389 ASN B 390 144.85 REMARK 500 REMARK 500 REMARK: NULL REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1E4K RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF SOLUBLE HUMAN IGG1 FC FRAGMENT-FC-GAMMA REMARK 900 RECEPTOR III COMPLEX REMARK 900 RELATED ID: 1T83 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR INCOMPLEX REMARK 900 WITH AN FC FRAGMENT OF IGG1 (ORTHORHOMBIC) REMARK 900 RELATED ID: 1H3U RELATED DB: PDB REMARK 900 STRUCTURAL ANALYSIS OF HUMAN IGG-FC GLYCOFORMS REVEALS A REMARK 900 CORRELATION BETWEEN GLYCOSYLATION AND STRUCTURAL INTEGRITY REMARK 900 RELATED ID: 1H3V RELATED DB: PDB REMARK 900 STRUCTURAL ANALYSIS OF HUMAN IGG-FC GLYCOFORMS REVEALS A REMARK 900 CORRELATION BETWEEN GLYCOSYLATION AND STRUCTURAL INTEGRITY REMARK 900 RELATED ID: 1OQX RELATED DB: PDB REMARK 900 G-2 GLYCOVARIANT OF HUMAN IGG FC BOUND TO MINIMIZED VERSIONOF REMARK 900 PROTEIN A CALLED Z34C REMARK 900 RELATED ID: 1FC1 RELATED DB: PDB REMARK 900 FC FRAGMENT (IGG1 CLASS) REMARK 900 RELATED ID: 2RCS RELATED DB: PDB REMARK 900 IMMUNOGLOBULIN 48G7 GERMLINE FAB - AFFINITY MATURATION OF AN REMARK 900 ESTEROLYTIC ANTIBODY REMARK 900 RELATED ID: 1AQK RELATED DB: PDB REMARK 900 THREE-DIMENSIONAL STRUCTURE OF A HUMAN FAB WITH HIGH AFFINITY FOR REMARK 900 TETANUS TOXOID REMARK 900 RELATED ID: 2IWG RELATED DB: PDB REMARK 900 COMPLEX BETWEEN THE PRYSPRY DOMAIN OF TRIM21 AND IGG FC REMARK 900 RELATED ID: 1D5B RELATED DB: PDB REMARK 900 UNLIGANDED MATURE OXY-COPE CATALYTIC ANTIBODY REMARK 900 RELATED ID: 1D5I RELATED DB: PDB REMARK 900 UNLIGANDED GERMLINE PRECURSOR OF AN OXY-COPE CATALYTIC ANTIBODY REMARK 900 RELATED ID: 1I7Z RELATED DB: PDB REMARK 900 ANTIBODY GNC92H2 BOUND TO LIGAND REMARK 900 RELATED ID: 2J6E RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AN AUTOIMMUNE COMPLEX BETWEEN A HUMAN IGM REMARK 900 RHEUMATOID FACTOR AND IGG1 FC REVEALS A NOVEL FC EPITOPE AND REMARK 900 EVIDENCE FOR AFFINITY MATURATION REMARK 900 RELATED ID: 1H3Y RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A HUMAN IGG1 FC- FRAGMENT,HIGH SALTCONDITION REMARK 900 RELATED ID: 1D6V RELATED DB: PDB REMARK 900 CONFORMATION EFFECTS IN BIOLOGICAL CATALYSIS INTRODUCED BY OXY-COPE REMARK 900 ANTIBODY MATURATION REMARK 900 RELATED ID: 1FCC RELATED DB: PDB REMARK 900 RELATED ID: 1H3W RELATED DB: PDB REMARK 900 STRUCTURAL ANALYSIS OF HUMAN IGG-FC GLYCOFORMS REVEALS A REMARK 900 CORRELATION BETWEEN GLYCOSYLATION AND STRUCTURAL INTEGRITY REMARK 900 RELATED ID: 1DN2 RELATED DB: PDB REMARK 900 FC FRAGMENT OF HUMAN IGG1 IN COMPLEX WITH AN ENGINEERED 13 RESIDUE REMARK 900 PEPTIDE DCAWHLGELVWCT-NH2 REMARK 900 RELATED ID: 1T89 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR INCOMPLEX REMARK 900 WITH AN FC FRAGMENT OF IGG1 (HEXAGONAL) REMARK 900 RELATED ID: 1H3T RELATED DB: PDB REMARK 900 STRUCTURAL ANALYSIS OF HUMAN IGG-FC GLYCOFORMS REVEALS A REMARK 900 CORRELATION BETWEEN GLYCOSYLATION AND STRUCTURAL INTEGRITY REMARK 900 RELATED ID: 1AJ7 RELATED DB: PDB REMARK 900 IMMUNOGLOBULIN 48G7 GERMLINE FAB ANTIBODY COMPLEXED WITH HAPTEN 5- REMARK 900 (PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID. AFFINITY MATURATION REMARK 900 OF AN ESTEROLYTIC ANTIBODY REMARK 900 RELATED ID: 1L6X RELATED DB: PDB REMARK 900 FC FRAGMENT OF RITUXIMAB BOUND TO A MINIMIZED VERSION OFTHE B- REMARK 900 DOMAIN FROM PROTEIN A CALLED Z34C REMARK 900 RELATED ID: 1BEY RELATED DB: PDB REMARK 900 ANTIBODY TO CAMPATH-1H HUMANIZED FAB REMARK 999 REMARK 999 SEQUENCE REMARK 999 T393A MUTATION AROSE DURING CLONING DBREF 2WAH A 237 445 UNP P01857 IGHG1_HUMAN 120 328 DBREF 2WAH B 237 445 UNP P01857 IGHG1_HUMAN 120 328 SEQADV 2WAH ALA A 393 UNP P01857 THR 276 ENGINEERED MUTATION SEQADV 2WAH ALA B 393 UNP P01857 THR 276 ENGINEERED MUTATION SEQRES 1 A 209 GLY PRO SER VAL PHE LEU PHE PRO PRO LYS PRO LYS ASP SEQRES 2 A 209 THR LEU MET ILE SER ARG THR PRO GLU VAL THR CYS VAL SEQRES 3 A 209 VAL VAL ASP VAL SER HIS GLU ASP PRO GLU VAL LYS PHE SEQRES 4 A 209 ASN TRP TYR VAL ASP GLY VAL GLU VAL HIS ASN ALA LYS SEQRES 5 A 209 THR LYS PRO ARG GLU GLU GLN TYR ASN SER THR TYR ARG SEQRES 6 A 209 VAL VAL SER VAL LEU THR VAL LEU HIS GLN ASP TRP LEU SEQRES 7 A 209 ASN GLY LYS GLU TYR LYS CYS LYS VAL SER ASN LYS ALA SEQRES 8 A 209 LEU PRO ALA PRO ILE GLU LYS THR ILE SER LYS ALA LYS SEQRES 9 A 209 GLY GLN PRO ARG GLU PRO GLN VAL TYR THR LEU PRO PRO SEQRES 10 A 209 SER ARG ASP GLU LEU THR LYS ASN GLN VAL SER LEU THR SEQRES 11 A 209 CYS LEU VAL LYS GLY PHE TYR PRO SER ASP ILE ALA VAL SEQRES 12 A 209 GLU TRP GLU SER ASN GLY GLN PRO GLU ASN ASN TYR LYS SEQRES 13 A 209 ALA THR PRO PRO VAL LEU ASP SER ASP GLY SER PHE PHE SEQRES 14 A 209 LEU TYR SER LYS LEU THR VAL ASP LYS SER ARG TRP GLN SEQRES 15 A 209 GLN GLY ASN VAL PHE SER CYS SER VAL MET HIS GLU ALA SEQRES 16 A 209 LEU HIS ASN HIS TYR THR GLN LYS SER LEU SER LEU SER SEQRES 17 A 209 PRO SEQRES 1 B 209 GLY PRO SER VAL PHE LEU PHE PRO PRO LYS PRO LYS ASP SEQRES 2 B 209 THR LEU MET ILE SER ARG THR PRO GLU VAL THR CYS VAL SEQRES 3 B 209 VAL VAL ASP VAL SER HIS GLU ASP PRO GLU VAL LYS PHE SEQRES 4 B 209 ASN TRP TYR VAL ASP GLY VAL GLU VAL HIS ASN ALA LYS SEQRES 5 B 209 THR LYS PRO ARG GLU GLU GLN TYR ASN SER THR TYR ARG SEQRES 6 B 209 VAL VAL SER VAL LEU THR VAL LEU HIS GLN ASP TRP LEU SEQRES 7 B 209 ASN GLY LYS GLU TYR LYS CYS LYS VAL SER ASN LYS ALA SEQRES 8 B 209 LEU PRO ALA PRO ILE GLU LYS THR ILE SER LYS ALA LYS SEQRES 9 B 209 GLY GLN PRO ARG GLU PRO GLN VAL TYR THR LEU PRO PRO SEQRES 10 B 209 SER ARG ASP GLU LEU THR LYS ASN GLN VAL SER LEU THR SEQRES 11 B 209 CYS LEU VAL LYS GLY PHE TYR PRO SER ASP ILE ALA VAL SEQRES 12 B 209 GLU TRP GLU SER ASN GLY GLN PRO GLU ASN ASN TYR LYS SEQRES 13 B 209 ALA THR PRO PRO VAL LEU ASP SER ASP GLY SER PHE PHE SEQRES 14 B 209 LEU TYR SER LYS LEU THR VAL ASP LYS SER ARG TRP GLN SEQRES 15 B 209 GLN GLY ASN VAL PHE SER CYS SER VAL MET HIS GLU ALA SEQRES 16 B 209 LEU HIS ASN HIS TYR THR GLN LYS SER LEU SER LEU SER SEQRES 17 B 209 PRO MODRES 2WAH ASN A 297 ASN GLYCOSYLATION SITE MODRES 2WAH ASN B 297 ASN GLYCOSYLATION SITE HET NAG C 1 14 HET NAG C 2 14 HET BMA C 3 11 HET MAN C 4 11 HET MAN C 5 11 HET MAN C 6 11 HET MAN C 7 11 HET MAN C 8 11 HET MAN C 9 11 HET NAG D 1 14 HET NAG D 2 14 HET BMA D 3 11 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE FORMUL 3 NAG 4(C8 H15 N O6) FORMUL 3 BMA 2(C6 H12 O6) FORMUL 3 MAN 6(C6 H12 O6) FORMUL 5 HOH *94(H2 O) HELIX 1 1 LYS A 246 MET A 252 1 7 HELIX 2 2 LEU A 309 ASN A 315 1 7 HELIX 3 3 SER A 354 LYS A 360 5 7 HELIX 4 4 LYS A 414 GLN A 419 1 6 HELIX 5 5 LEU A 432 TYR A 436 5 5 HELIX 6 6 LYS B 246 MET B 252 1 7 HELIX 7 7 LEU B 309 ASN B 315 1 7 HELIX 8 8 SER B 354 LEU B 358 5 5 HELIX 9 9 LYS B 414 GLN B 419 1 6 HELIX 10 10 LEU B 432 TYR B 436 5 5 SHEET 1 AA 4 SER A 239 PHE A 243 0 SHEET 2 AA 4 GLU A 258 VAL A 266 -1 O THR A 260 N PHE A 243 SHEET 3 AA 4 TYR A 300 THR A 307 -1 O TYR A 300 N VAL A 266 SHEET 4 AA 4 LYS A 288 THR A 289 -1 O LYS A 288 N VAL A 305 SHEET 1 AB 4 SER A 239 PHE A 243 0 SHEET 2 AB 4 GLU A 258 VAL A 266 -1 O THR A 260 N PHE A 243 SHEET 3 AB 4 TYR A 300 THR A 307 -1 O TYR A 300 N VAL A 266 SHEET 4 AB 4 GLU A 293 GLU A 294 -1 O GLU A 293 N ARG A 301 SHEET 1 AC 4 VAL A 282 VAL A 284 0 SHEET 2 AC 4 LYS A 274 VAL A 279 -1 O TRP A 277 N VAL A 284 SHEET 3 AC 4 TYR A 319 SER A 324 -1 O LYS A 320 N TYR A 278 SHEET 4 AC 4 ILE A 332 ILE A 336 -1 O ILE A 332 N VAL A 323 SHEET 1 AD 4 GLN A 347 LEU A 351 0 SHEET 2 AD 4 GLN A 362 PHE A 372 -1 O THR A 366 N LEU A 351 SHEET 3 AD 4 PHE A 404 ASP A 413 -1 O PHE A 404 N PHE A 372 SHEET 4 AD 4 TYR A 391 ALA A 393 -1 O LYS A 392 N LYS A 409 SHEET 1 AE 4 GLN A 347 LEU A 351 0 SHEET 2 AE 4 GLN A 362 PHE A 372 -1 O THR A 366 N LEU A 351 SHEET 3 AE 4 PHE A 404 ASP A 413 -1 O PHE A 404 N PHE A 372 SHEET 4 AE 4 VAL A 397 LEU A 398 -1 O VAL A 397 N PHE A 405 SHEET 1 AF 4 GLN A 386 PRO A 387 0 SHEET 2 AF 4 ALA A 378 SER A 383 -1 O SER A 383 N GLN A 386 SHEET 3 AF 4 PHE A 423 MET A 428 -1 O SER A 424 N GLU A 382 SHEET 4 AF 4 THR A 437 LEU A 441 -1 O THR A 437 N VAL A 427 SHEET 1 BA 4 SER B 239 PHE B 243 0 SHEET 2 BA 4 GLU B 258 VAL B 266 -1 O THR B 260 N PHE B 243 SHEET 3 BA 4 TYR B 300 THR B 307 -1 O TYR B 300 N VAL B 266 SHEET 4 BA 4 LYS B 288 THR B 289 -1 O LYS B 288 N VAL B 305 SHEET 1 BB 4 SER B 239 PHE B 243 0 SHEET 2 BB 4 GLU B 258 VAL B 266 -1 O THR B 260 N PHE B 243 SHEET 3 BB 4 TYR B 300 THR B 307 -1 O TYR B 300 N VAL B 266 SHEET 4 BB 4 GLU B 293 GLU B 294 -1 O GLU B 293 N ARG B 301 SHEET 1 BC 4 VAL B 282 VAL B 284 0 SHEET 2 BC 4 LYS B 274 VAL B 279 -1 O TRP B 277 N VAL B 284 SHEET 3 BC 4 TYR B 319 SER B 324 -1 O LYS B 320 N TYR B 278 SHEET 4 BC 4 ILE B 332 ILE B 336 -1 O ILE B 332 N VAL B 323 SHEET 1 BD 7 GLN B 347 LEU B 351 0 SHEET 2 BD 7 GLN B 362 PHE B 372 -1 O THR B 366 N LEU B 351 SHEET 3 BD 7 PHE B 404 ASP B 413 -1 O PHE B 404 N PHE B 372 SHEET 4 BD 7 TYR B 391 ALA B 393 -1 O LYS B 392 N LYS B 409 SHEET 5 BD 7 PHE B 404 ASP B 413 -1 O LYS B 409 N LYS B 392 SHEET 6 BD 7 VAL B 397 LEU B 398 -1 O VAL B 397 N PHE B 405 SHEET 7 BD 7 PHE B 404 ASP B 413 -1 O PHE B 405 N VAL B 397 SHEET 1 BE 4 GLN B 386 PRO B 387 0 SHEET 2 BE 4 ALA B 378 SER B 383 -1 O SER B 383 N GLN B 386 SHEET 3 BE 4 PHE B 423 MET B 428 -1 O SER B 424 N GLU B 382 SHEET 4 BE 4 THR B 437 LEU B 441 -1 O THR B 437 N VAL B 427 SSBOND 1 CYS A 261 CYS A 321 1555 1555 2.05 SSBOND 2 CYS A 367 CYS A 425 1555 1555 2.04 SSBOND 3 CYS B 261 CYS B 321 1555 1555 2.04 SSBOND 4 CYS B 367 CYS B 425 1555 1555 2.08 LINK ND2 ASN A 297 C1 NAG C 1 1555 1555 1.45 LINK ND2 ASN B 297 C1 NAG D 1 1555 1555 1.44 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.45 LINK O4 NAG C 2 C1 BMA C 3 1555 1555 1.44 LINK O6 BMA C 3 C1 MAN C 4 1555 1555 1.45 LINK O3 BMA C 3 C1 MAN C 8 1555 1555 1.45 LINK O6 MAN C 4 C1 MAN C 5 1555 1555 1.46 LINK O3 MAN C 4 C1 MAN C 7 1555 1555 1.45 LINK O2 MAN C 5 C1 MAN C 6 1555 1555 1.45 LINK O2 MAN C 8 C1 MAN C 9 1555 1555 1.45 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.45 LINK O4 NAG D 2 C1 BMA D 3 1555 1555 1.45 CISPEP 1 TYR A 373 PRO A 374 0 0.51 CISPEP 2 TYR B 373 PRO B 374 0 -2.27 CRYST1 49.391 74.977 149.200 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020247 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013337 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006702 0.00000